|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garland SM, Hernandez-Avila M, Wheeler CM,
Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M,
Bryan J, et al Females United to Unilaterally Reduce
Endo/Ectocervical Disease (FUTURE) I Investigators, : Quadrivalent
vaccine against human papillomavirus to prevent anogenital
diseases. N Engl J Med. 356:1928–1943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ozato K, Shin DM, Chang TH and Morse HC
III: TRIM family proteins and their emerging roles in innate
immunity. Nat Rev Immunol. 8:849–860. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gallouet AS, Ferri F, Petit V, Parcelier
A, Lewandowski D, Gault N, Barroca V, Le Gras S, Soler E, Grosveld
F, et al: Macrophage production and activation are dependent on
TRIM33. Oncotarget. 8:5111–5122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song S, Ge Q, Wang J, Chen H, Tang S, Bi
J, Li X, Xie Q and Huang X: TRIM-9 functions in the UNC-6/UNC-40
pathway to regulate ventral guidance. J Genet Genomics. 38:1–11.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raheja R, Liu Y, Hukkelhoven E, Yeh N and
Koff A: The ability of TRIM3 to induce growth arrest depends on
RING-dependent E3 ligase activity. Biochem J. 458:537–545. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwamborn JC, Berezikov E and Knoblich
JA: The TRIM-NHL protein TRIM32 activates microRNAs and prevents
self-renewal in mouse neural progenitors. Cell. 136:913–925. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin J, Kim TH, Park N, Shin D, Choi HI,
Cho S, Park JB and Kim JH: TRIM71 suppresses tumorigenesis via
modulation of Lin28B-let-7-HMGA2 signaling. Oncotarget.
7:79854–79868. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Y, Yu Y, Yang Y, Yang M, Zhou L,
Huang X and Qin Q: Fish TRIM8 exerts antiviral roles through
regulation of the proinflammatory factors and interferon signaling.
Fish Shellfish Immunol. 54:435–444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH
and Gao WQ: TRIM59 is up-regulated in gastric tumors, promoting
ubiquitination and degradation of p53. Gastroenterology.
147:1043–1054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tyybakinoja A, Vilpo J and Knuutila S:
High-resolution oligonucleotide array-CGH pinpoints genes involved
in cryptic losses in chronic lymphocytic leukemia. Cytogenet Genome
Res. 118:8–12. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chung YL and Wu ML: Promyelocytic
leukaemia protein links DNA damage response and repair to hepatitis
B virus-related hepatocarcinogenesis. J Pathol. 230:377–387. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai WW, Wang Z, Yiu TT, Akdemir KC, Xia
W, Winter S, Tsai CY, Shi X, Schwarzer D, Plunkett W, et al: TRIM24
links a non-canonical histone signature to breast cancer. Nature.
468:927–932. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang S, Kollipara RK, Humphries CG, Ma SH,
Hutchinson R, Li R, Siddiqui J, Tomlins SA, Raj GV and Kittler R:
The ubiquitin ligase TRIM25 targets ERG for degradation in prostate
cancer. Oncotarget. 7:64921–64931. 2016.PubMed/NCBI
|
|
16
|
Herquel B, Ouararhni K, Khetchoumian K,
Ignat M, Teletin M, Mark M, Béchade G, Van Dorsselaer A,
Sanglier-Cianférani S, Hamiche A, et al: Transcription cofactors
TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes
that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci
USA. 108:pp. 8212–8217. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim WJ, Wittner BS, Amzallag A, Brannigan
BW, Ting DT, Ramaswamy S, Maheswaran S and Haber DA: The WTX tumor
suppressor interacts with the transcriptional corepressor TRIM28. J
Biol Chem. 290:14381–14390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pineda CT and Potts PR: Oncogenic
MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by
ubiquitinating and degrading AMPK in cancer. Autophagy. 11:844–846.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K,
Ohi M, Inoue Y, Mohri Y, Miki C and Kusunoki M: KAP1 is associated
with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol.
17:821–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Addison JB, Koontz C, Fugett JH, Creighton
CJ, Chen D, Farrugia MK, Padon RR, Voronkova MA, McLaughlin SL,
Livengood RH, et al: KAP1 promotes proliferation and metastatic
progression of breast cancer cells. Cancer Res. 75:344–355. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Chen DT, Kurtyka C, Rawal B, Fulp
WJ, Haura EB and Cress WD: Tripartite motif containing 28 (Trim28)
can regulate cell proliferation by bridging HDAC1/E2F interactions.
J Biol Chem. 287:40106–40118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y,
Wang X, Li J and Song L: Knockdown of FLOT1 impairs cell
proliferation and tumorigenicity in breast cancer through
upregulation of FOXO3a. Clin Cancer Res. 17:3089–3099. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fingar DC, Richardson CJ, Tee AR, Cheatham
L, Tsou C and Blenis J: mTOR controls cell cycle progression
through its cell growth effectors S6K1 and 4E-BP1/eukaryotic
translation initiation factor 4E. Mol Cell Biol. 24:200–216. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pópulo H, Lopes JM and Soares P: The mTOR
signalling pathway in human cancer. Int J Mol Sci. 13:1886–1918.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Czerwińska P, Shah PK, Tomczak K, Klimczak
M, Mazurek S, Sozańska B, Biecek P, Korski K, Filas V, Mackiewicz
A, et al: TRIM28 multi-domain protein regulates cancer stem cell
population in breast tumor development. Oncotarget. 8:863–882.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cammas F, Mark M, Dollé P, Dierich A,
Chambon P and Losson R: Mice lacking the transcriptional
corepressor TIF1beta are defective in early postimplantation
development. Development. 127:2955–2963. 2000.PubMed/NCBI
|
|
27
|
Seki Y, Kurisaki A, Watanabe-Susaki K,
Nakajima Y, Nakanishi M, Arai Y, Shiota K, Sugino H and Asashima M:
TIF1beta regulates the pluripotency of embryonic stem cells in a
phosphorylation-dependent manner. Proc Natl Acad Sci USA. 107:pp.
10926–10931. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei C, Cheng J, Zhou B, Zhu L, Khan MA, He
T, Zhou S, He J, Lu X, Chen H, et al: Tripartite motif containing
28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1
protein. Sci Rep. 6:298222016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Jiang J, Li Q, Ma H, Xu Z and Gao
Y: KAP1 is overexpressed in hepatocellular carcinoma and its
clinical significance. Int J Clin Oncol. 21:927–933. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin LF, Li CF, Wang WJ, Yang WM, Wang DD,
Chang WC, Lee WH and Wang JM: Loss of ZBRK1 contributes to the
increase of KAP1 and promotes KAP1-mediated metastasis and invasion
in cervical cancer. PLoS One. 8:e730332013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pineda CT, Ramanathan S, Fon Tacer K, Weon
JL, Potts MB, Ou YH, White MA and Potts PR: Degradation of AMPK by
a cancer-specific ubiquitin ligase. Cell. 160:715–728. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Molinolo AA, Marsh C, El Dinali M, Gangane
N, Jennison K, Hewitt S, Patel V, Seiwert TY and Gutkind JS: mTOR
as a molecular target in HPV-associated oral and cervical squamous
carcinomas. Clin Cancer Res. 18:2558–2568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mura M, Hopkins TG, Michael T, Abd-Latip
N, Weir J, Aboagye E, Mauri F, Jameson C, Sturge J, Gabra H, et al:
LARP1 post-transcriptionally regulates mTOR and contributes to
cancer progression. Oncogene. 34:5025–5036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng T, Zheng L, Liu F, Xu X, Mao S, Wang
X, Liu J, Lu Y, Zhao W, Yu X, et al: Growth factor progranulin
promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR
signaling pathway. Oncotarget. 7:58381–58395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Biewenga P, Buist MR, Moerland PD, Ver
Loren van Themaat E, van Kampen AH, ten Kate FJ and Baas F: Gene
expression in early stage cervical cancer. Gynecol Oncol.
108:520–526. 2008. View Article : Google Scholar : PubMed/NCBI
|
